Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Short Message Service Reminder Nudge for Parents and Influenza Vaccination Uptake in Children and Adolescents with Special Risk Medical Conditions: The Flutext-4U Randomized Clinical Trial

Children with chronic medical conditions are at increased risk of severe influenza. Uptake of influenza vaccination in children and adolescents with these identified special risk medical conditions is suboptimal.

Research

Spatiotemporal distributions of under-five mortality in Ethiopia between 2000 and 2019

Under-five mortality declined in the last two decades in Ethiopia, but sub-national and local progress remains unclear. This study aimed to investigate the spatiotemporal distributions and ecological level factors of under-five mortality in Ethiopia. Data on under-five mortality were obtained from five different Ethiopian Demographic and Health Surveys conducted in 2000, 2005, 2011, 2016, and 2019. Environmental and healthcare access data were obtained from different publicly available sources.

Research

The human toll and humanitarian crisis of the Russia-Ukraine war: the first 162 days

We examined the human toll and subsequent humanitarian crisis resulting from the Russian invasion of Ukraine, which began on 24 February 2022.

Research

Two cases of Leclercia adecarboxylata septic arthritis in immunocompetent paediatric patients

Leclercia adecarboxylata is a rare cause of septic arthritis in children, and has intrinsic resistance to common antibiotics. We describe two cases of L. adecarboxylata septic arthritis in children that required re-presentation to hospital with prolonged treatment, and highlight the importance of considering L. adecarboxylata as a potential cause of infection among children with penetrating injuries and associated environmental exposure.

Research

The potential of antisense oligonucleotide therapies for inherited childhood lung diseases

Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient's genetic mutation, in particular those lesions that compromise normal pre-mRNA processing. Antisense oligonucleotides can alter gene expression through a variety of mechanisms as determined by the chemistry and antisense oligomer design.

News & Events

Flying the flag for WA research thanks to Business Events Aspire Awards

Dr Matthew ‘Tepi’ Mclaughlin is the 2022 The Kids Research Institute Australia Aspire Award winner - coordinated by Western Australia’s peak body for business events, Business Events Perth.

News & Events

The Impact of Poverty - interview with Steve Zubrick

Growing up poor is about more than just the size of your bank account. Read the new CoLab Impact of Poverty Evidence Report.

News & Events

$1.2million in funding secured for two innovative projects

The Kids researchers are collaborating on two major projects that today received $1.2million in funding from MTPConnect.

News & Events

The Kids welcomes State Government commitment to research

The Kids Research Institute Australia, has welcomed the State Government's budget commitment to innovation and medical research.

News & Events

Grant to expand innovative consumer involvement program

A $3.2 million grant from Lotterywest will allow the highly successful Consumer Involvement Program to be expanded to 18 other WA organisations.